Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.

Jacobo Rogado RevueltaFernando PozoKevin TrouléJosé Miguel Sánchez-TorresNuria Romero-LaordenRebeca MondejarOlga DonnayAnabel BallesterosVilma Pacheco-BarciaJavier AspaFátima Al-ShahrourArantzazu AlfrancaRamon Colomer

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)

Our study suggests that patients with excess weight who receive anti-PD-1 immune checkpoint inhibitors diagnosed with non-small cell lung cancer have a better outcome. This effect is specific to patients receiving immunotherapy.

Keyphrases

body mass index
weight loss
physical activity
weight gain
body weight
type diabetes
skeletal muscle